curriculum vitae martha f. rogers, md, faap rank

21
Martha F. Rogers, M.D., FAAP – August 2012 1 MARTHA F. ROGERS, MD, FAAP Rank: Research Professor Director, Lillian Carter Center for Global Health & Social Responsibility Nell Hodgson Woodruff School of Nursing Emory University Telephone: (404) 727-8424 Email: mfroger@emory.edu Alternate address: 325 Swanton Way Decatur, GA 30030 [email protected] Tel: 404-592-1431 Mobile: 404-358-1033 EDUCATION Dates Institution and Location Degree 1972-1976 Medical College of Georgia Medical Doctor 1969-1972 Emory University Pre-Med LICENSES AND CERTIFICATIONS Dates Type License Number 1981 – 5/2015 Composite State Board of Medical Examiners #031315 1981 Fellow, American Academy of Pediatrics 1983 Board Eligible for Preventive Medicine HONORS AND AWARDS Year Name of Award 1999 Certificate of Commendation, American Academy of Pediatrics 1999 Dept of Health and Human Services Secretary’s Award for Distinguished Service 1984, 1990, and 1992 US Public Health Service Unit Commendation (3 awards) 1986 and 1989 US Public Health Service Commendation Medal (2 awards) 1989, 1994 and 1996 US Public Health Service Outstanding Unit Citation (3 awards) 1989 US Public Health Service Outstanding Service Medal 1989, 1990, 1993, 1996 and 1997 Nominated, Centers for Disease Control and Prevention Charles W. Sheppard Award for outstanding scientific publication

Upload: others

Post on 11-Feb-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

Martha F. Rogers, M.D., FAAP – August 2012

1

MARTHA F. ROGERS, MD, FAAP Rank: Research Professor

Director, Lillian Carter Center for Global Health & Social Responsibility Nell Hodgson Woodruff School of Nursing

Emory University Telephone: (404) 727-8424 Email: [email protected]

Alternate address: 325 Swanton Way

Decatur, GA 30030 [email protected]

Tel: 404-592-1431 Mobile: 404-358-1033

EDUCATION Dates Institution and Location Degree

1972-1976 Medical College of Georgia Medical Doctor

1969-1972 Emory University Pre-Med

LICENSES AND CERTIFICATIONS Dates Type License Number

1981 – 5/2015 Composite State Board of Medical Examiners #031315

1981 Fellow, American Academy of Pediatrics

1983 Board Eligible for Preventive Medicine

HONORS AND AWARDS Year Name of Award

1999 Certificate of Commendation, American Academy of Pediatrics

1999 Dept of Health and Human Services Secretary’s Award for Distinguished Service

1984, 1990, and 1992 US Public Health Service Unit Commendation (3 awards)

1986 and 1989 US Public Health Service Commendation Medal (2 awards)

1989, 1994 and 1996 US Public Health Service Outstanding Unit Citation (3 awards)

1989 US Public Health Service Outstanding Service Medal

1989, 1990, 1993, 1996 and 1997

Nominated, Centers for Disease Control and Prevention Charles W. Sheppard Award for outstanding scientific publication

Martha F. Rogers, M.D., FAAP – August 2012

2

1992 Regular US Public Health Service Commissioned Corps Appointment

1992 Surgeon General's Exemplary Service Medal

1993 National Center for Infectious Disease Research, Epidemiology and Laboratory Award for Investigation of Idiopathic CD4 T-lymphocytopenia

1993 US Public Health Service Meritorious Service Award

PROFESSIONAL POSITIONS Month, Year Position Institution June 2008-present Director Lillian Carter Center for Global

Health and Social Responsibility

Nov 2002-present Research Professor Nell Hodgson Woodruff School of Nursing, Emory University

June 2001 - present Director, AIDS Programs

Task Force for Global Health

Jun 2001- June 2001 Senior Scientist Task Force for Global Health

Sept 1997-Jun 2000 Associate Director for Science Centers for Disease Control and Prevention

Mar 1989-Sept 1997 Chief, Epidemiology Branch Centers for Disease Control and Prevention

Mar 1984-Feb 1989 Chief, Pediatric and Family Studies Centers for Disease Control and Prevention

Jun 1981-Mar 1984 EIS Officer Centers for Disease Control and Prevention

Jul 1976-Jun 1979 Pediatric Residency Phoenix Hospitals Affiliated Pediatric Program

SCHOLARSHIP: GRANTS AND OTHER FUNDING

Research Grants Under Review (in reverse chronological order)

Educational, Training, and Program Grants Funded (in reverse chronological order) African Health Workforce Project (M Rogers) Role and effort: PI, 35% effort Grant number: S5033 Funding agency: CDC, Associated Schools of Public Health Total costs: $800,000/year

Martha F. Rogers, M.D., FAAP – August 2012

3

Funding period: 8/15/2012 – 8/14/2017 Review of manuscripts and protocols Role and effort : Consultant, 35% Grant number: IPA Funding agency: CDC Div HIV/AIDS Total costs: 30% of annual salary Funding period: 6/30/2005 – present Review of manuscripts and protocols Role and effort : Consultant, 20% Grant number: IPA Funding agency: CDC Global AIDS Programs Total costs: 20% of annual salary Funding period: 6/30/2008 – present Kenya Health Workforce Project (M. Rogers) Role and effort : PI, 30% effort Grant number: S3800 Funding agency: CDC, Associated Schools of Public Health Total costs: $5,207,769 Funding period: 9/27/2006 – 9/26/2012 Development of Interventions for Multiply at Risk Groups for HIV (M. Rogers, PI) Role and effort: Project Director ; 15% effort Grant number: contract number 200-2010-34748 Funding agency: CDC Global AIDS Program Total cost: $245,000 Funding period: 6/1/2010 – 6/6/2012 Project Enhance (M. Rogers, PI) Role and effort : Project Director, (25%) Grant number: contract number 200-2009-M-31762 Funding agency: CDC Global AIDS Program Total cost: $250,000 Funding period: 8/20/2009 – 5/23/2011 Prevention with Positives (M. Rogers, PI) Role and effort: Director, 30% effort Grant number: contract number GS-ooF-0001T Funding agency: CDC Global AIDS Program Total costs: $700,000 Funding period: 12/29/2006 – 9/15/2010 African Children Orphaned and At-risk for AIDS (Mark Aguirre, PI) Role and effort : Consultant, 10% Grant number: Funding agency: HOPE Worldwide OVC Program

Martha F. Rogers, M.D., FAAP – August 2012

4

Total costs: $100,000 Funding period: 5/30/2006 – 4/15/2008 TB/HIV Training Program (M. Rogers) Role and effort : Contract Director, 10% effort Grant number Funding agency: CDC Global AIDS Program Program Total costs: $115,000 Funding period: mm/dd/2005 –mm/dd/2006 Diagnosing Infants with HIV (M. Rogers) Role and effort: Contract Director, 20% Grant number Funding agency: CDC Global AIDS Program Total costs: $110,000 Funding period: mm/dd/2005 – mm/dd/2006 Socioemotional Development Conference (M. Rogers) Role and effort: Project Director, 5% Grant number Funding agency: Georgia Department of Early Learning (2 contracts) Total costs: $150,000 Funding period: mm/dd/2005 – mm/dd/2006 Engaging Parents (M.Rogers) Role and effort : Project Director, 10% Grant number Funding agency: Georgia Division of Public Health Total costs: $135,000 Funding period: mm/dd/2005 – mm/dd/2006 Video production for Parenting in the Real World (M. Rogers) Role and effort : Project Director, 15% effort Grant number Marguerite Casey Foundation Total costs: $40,000 Funding period: mm/dd/2004 – mm/dd/2005 Counselor Training for Couples Counseling (M. Rogers) Role and effort: Project Director, 30% effort Grant number Funding agency: CDC Global AIDS Program Total costs: $250,000 Funding period: mm/dd/2004 – mm/dd/2005 Parenting in the Real World (M. Rogers) Role and effort : Project Director, 30% effort Grant number

Martha F. Rogers, M.D., FAAP – August 2012

5

Funding agency: GA Dept of Early Learning Total costs: $350,000 Funding period: mm/dd/2004 – mm/dd/2005 Enhancing Early Childhood Comprehensive Systems (M. Rogers) Role and effort : Contractor, 5% effort Grant number Funding agency: Georgia Department of Human Resources Total costs: $10,000 Funding period: 9/27/2004 – 11/30/2005 Health Campaign for Sheltering Arms Childcare (M. Rogers) Role and effort: Consultant, 15% effort Grant number Funding agency: Georgia Healthcare Foundation Total costs: $92,000 Funding period: mm/dd/2004 – mm/dd/2004 Reproductive Health Needs of Women in Displaced Settings (M Rogers) Role and effort: Director, 20% effort Grant number Funding agency: CDC Foundation Total costs: $60,000 Funding period: mm/dd/2003 – mm/dd/2005 Title of grant: Environmental Education for Children (M. Rogers) Role and effort: Co-director, 25% effort Grant number Funding agency: ATSDR Total costs: $150,000 Funding period: mm/dd/2003 – mm/dd/2004 AIDS Orphans in Rwanda (M. Rogers) Role and effort : Director, 20% Grant number Funding agency: World Bank Total costs: $60,000 Funding period: mm/dd/2003 – mm/dd/2003 Evaluation of Parenting Course (M. Rogers) Role and effort: Co-director, 20% effort Grant number Funding agency: Regional Head Start Office Total costs: $68,000 Funding period: mm/dd/2003 – mm/dd/2003 Title of the grant: Parenting in the Real World (M. Rogers)

Martha F. Rogers, M.D., FAAP – August 2012

6

Role and effort: Director, 40% effort Grant number Funding agency: Robert Wood Johnson Foundation Total costs: $250,000 Funding period: mm/dd/2002 – mm/dd/2004 Title of grant: Center for Child Wellbeing (Mark Rosenberg) Role and % effort : Director, 100% Grant number Funding Agency: Robert Wood Foundation Total costs: $400,000 Funding period: mm/dd/2001 – mm/dd/2004 Child Needs Assessment Toolkit (M. Rogers) Role and effort : Director, 25% effort Grant number Funding agency: World Bank Total costs: $60,000 Funding period: mm/dd/2001 – mm/dd/2003

SCHOLARSHIP: PUBLICATIONS

Original Articles in Peer-Reviewed Journals (in reverse chronological order; please include the PubMedCentral ID Number (PMCID) if available)

Rogers MF, Kaplan AM, Ben-Ora A. Fetal hydrocephalus: use of ultrasound in diagnosis and management. Perinatology-Neonatology 1980;4:31-34.

Rogers MF, Morens DM, Stewart JA, et al. National case-control study of Kaposi's sarcoma and

Pneumocystis carinii pneumonia in homosexual men: part 2, laboratory results. Ann Intern Med 1983;99:151-158.

Jaffe HW, Choi K, Thomas PA, Haverkos HW, Auerbach DM, Guinan ME, Rogers MF, et al.

National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: part 1, epidemiologic results. Ann Intern Med 1983;99:145-150.

Rogers MF, Schonberger LB, Hurwitz ES, Rowley DL. National Reye syndrome surveillance,

1982. Pediatrics 1985;75:260-264. Hurwitz ES, Barrett M, Rogers MF, Schonberger LB. Grade I Reye's syndrome. [Letter to ed]. N

Engl J Med 1984;310:128-129. Rogers MF, Schonberger LB, Hurwitz ES, Rowley DL. National Reye syndrome Surveillance,

Martha F. Rogers, M.D., FAAP – August 2012

7

1982. February edition of MMWR Quarterly Summary. Patriarca PA, Rogers MF, Morens DM, et al. Kawasaki syndrome: association with the

application of rug shampoo. Lancet 1982;2:578-80. Centers for Disease Control Task Force on Kaposi's Sarcoma and Opportunistic Infections.

Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med 1982;306:248-52.

Rogers MF. AIDS in children: a review of the clinical, epidemiologic and public health aspects.

Pediatric Infectious Disease 1985;4:230-236. Rogers MF, Budnick LD, Kirson I, et al. An outbreak hemolytic-uremic syndrome in

Sacramento, California. West J Med l986;l44:169-73. Rogers MF, Kochel R, Hurwitz ES, et al. Kawasaki syndrome: is exposure to rug shampoo

important? AJDC l985;l39:777-779. Rogers MF, Rutherford GW, Alexander SR, et al. A population-based study of

hemolytic-uremic syndrome in Oregon, 1979-1982. Am J Epidemiol l986;l23:137-42. Rogers MF, Lifson, AR. AIDS and HTLV-III/LAV infection in adolescents. Seminars in

Adolescent Med l986;2:l63. Rogers MF, Ewing EP, Warfield D, et al. Virologic studies of HTLV-III/LAV in pregnancy: case

report of a woman with AIDS. Obstet Gynecol l986;68:25. Friedland GH, Saltzman BR, Rogers MF, et. al. Lack of transmission of HTLV-III/LAV infection to

household contacts of patients with AIDS and AIDS related complex with oral candidiasis. N Engl J Med l986;3l4:344-49.

Barrett MJ, Hurwitz ES, Schonberger LB, Rogers MF. Changing epidemiology of Reye

syndrome in the United States. Pediatrics 1986; 77:598-602. Rogers MF. AIDS in children. Pediatria l986; 24:l22. Rogers MF. Pediatric AIDS. New York Medical Quarterly l987; 7:68-73. Rogers MF. The epidemiology of pediatric HTLV-III/LAV infection. In: Wormser GP, ed. AIDS

and other manifestations of human immunodeficiency virus infection. New York: Noyes publications, l987:36-47.

Martha F. Rogers, M.D., FAAP – August 2012

8

Rogers MF. The control of perinatally acquired HIV infection and the care of infected mothers,

infants, and children. West J Med l987;l47:l09-ll0. Rogers MF, Thomas PA, Starcher ET, Noa MC, Bush TJ, Jaffe HW. AIDS in children: report of

the Centers for Disease Control national surveillance, l982-l985. Pediatrics l987;79:l008-l0l4. Rogers MF, Williams WW. AIDS in blacks and Hispanics: implications for prevention. Issues in

Science and Technology l987;3:89-94. Rogers MF. Pediatric HIV infection: epidemiology, etiopathogenesis, and transmission.

Pediatric Annals 1988;17:324-331. Rogers MF. Perinatal HIV-1 infection. In: Kaslow RA, Francis D, eds. The epidemiology of AIDS.

New York: Oxford University Press, 1989:231-241. Rogers MF. AIDS: what parents should know to protect themselves and their families. PTA

Today l987;l2:l2-l3. Bennett JV, Holmberg SD, Rogers MF, Solomon SL. Infectious and Parasitic Diseases. In: Amler

RW, Dull HB, eds. closing the gap: the burden of unnecessary illness. New York: Oxford University Press, l987:l02-ll4.

Kinney JS, Gross TP, Porter CC, Rogers MF, Schonberger LB, Hurwitz ES. Hemolytic-uremic

syndrome: a population-based study in Washington, DC, and Baltimore Maryland. Am J Public Health 1988;78:64-65.

Rogers, MF. Classification system for human immunodeficiency virus (HIV) infection in

children under l3 years of age. In: Schinazi RF, Nahmias AJ, eds. AIDS in children, Adolescents and Heterosexual Adults. New York: Elsevier, l988:235-240.

Rogers MF. How do children acquire AIDS? Nebraska Perinatal Letter 1988;3:5-6. Rogers MF. Breast-feeding and HIV infection. Lancet 1987;2:1278. Rogers MF, Oleske J, Scott GB, Haverkos HW, Meade PB. AIDS in mothers and babies. Cont.

OB/GYN 1985;SI:126-141. Onorato IM, Orenstein WA, Hinman AR, Rogers MF, Koplan JP. Immunization of asymptomatic

HIV-infected children with measles vaccine: assessment of risks and benefits. Medical Decis Making l989;9:76-83.

Martha F. Rogers, M.D., FAAP – August 2012

9

Koonin LM, Ellerbrock TV, Atrash HK, Rogers MF, et al. Pregnancy- associated deaths due to

AIDS in the United States. JAMA 1989;251:1306-1309. Selwyn PA, Schoenbaum EE, Rogers MF, Davenny K, et al. Prospective study of human

immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289-1294.

Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K, Rogers MF, Feiner C, Friedland G.

Risk factors for HIV infection in IV drug users. N Engl J Med 1989;321:874-879. Rogers MF, Ou C-Y, Rayfield M, et al. Use of the polymerase chain reaction for early detection

of HIV proviral sequences in infants born to HIV-seropositive mothers. N Engl J Med 1989;320:1649-1654.

Rogers MF, White C, Sanders R, et al. Lack of evidence of transmission of HIV from infected

children to their household contacts. Pediatrics 1990;85:210-214. Selwyn PA, Carter RJ, Schoenbaum EE, Robertson VJ, Klein RS, Rogers, MF. Knowledge of HIV

antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA l989; 26l:3567-3571.

Rogers MF, Schochetman G. HIV infection in infants. In: Testing for AIDS and other retrovirus

infections: a practical desk reference. New York: Springer-Verlag, 1990: (in press). Ellerbrock TV, Rogers MF. Epidemiology of HIV infection in women in the United States. In:

Minkoff H. (in press). Jones DS, Rogers MF. Human immunodeficiency virus infection in children in day care.

Seminars in pediatric infectious diseases 1990;1:280-286. Friedland G, Kahl P, Saltzman B, Rogers M, Feiner C, Mayers M, Schable C, Klein RS. Additional

evidence for lack of transmission of HIV infection by close interpersonal (casual) contact. AIDS l990, 4:639-644.

Rogers MF, Ou C-Y, Kilbourne B, Schochetman G. Advances and problems in the diagnosis of

HIV infection in infants. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents. Baltimore:Williams & Wilkins, 1991:159-174.

Bennett JV, Rogers MF. Child survival and perinatal infections with human immunodeficiency

virus. AJDC 1991; 145:1242-1247.

Martha F. Rogers, M.D., FAAP – August 2012

10

Caldwell MB, Rogers MF. Epidemiology of pediatric HIV infection. Pediatr Clin North Am

1991;38:1-16. Rogers MF, Ou C-Y, Kilbourne B, Schochetman G. Advances and problems in the diagnosis of

human immunodeficiency virus infection in infants. Pediatr Infect Dis J 1991;10:523-531. Rogers MF, Ou C-Y, Kilbourne B, Schochetman G. Early identification of human

immunodeficiency virus infection in infants. J Pediatr 1991;118:490-491. Abrams EJ, Rogers MF. Paediatric HIV infection. Bailliere's Clinical Haematology 1991;4:xxx-

xxx. Parekh BS, Shaffer N, Pau C-P, Abrams E, Thomas P, Pollack H, Bamji M, Kaul A, Schochetman

G, Rogers M, George JR and the NYC Perinatal HIV Transmission Collaborative Study. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS 1991;5:1179-1184.

Peterson HB, Rogers MF. Perinatal transmission of HIV. In: DeVita VT, Hellman S, Rosenberg

SA, eds. AIDS: Etiology, diagnosis, treatment and prevention. Philadelphia: JB Lippincott Co., 1992:471-478

Simonds RJ, Holmberg SD, Hurwitz RL, Coleman TR, Bottenfield S, Conley LJ, Kohlenberg SH,

Castro KG, Dahan BA, Schable CA, Rayfield MA, Rogers MF. Transmission of human immunodeficiency virus (HIV) from an HIV-seronegative organ and tissue donor. N Engl J Med 1992; 326:726-32

Darrow WW, Peterman TA, Jaffe HW, Rogers MF, Curran JW, Beral V. Kaposi's sarcoma and

exposure to faeces. Lancet 1992;339:685 Rogers MF. Donor/recipient HIV testing: Balancing medical practice with public health. J

Transplant Coordination 1992; 2:54-56 Rogers MF, Kilbourne BW. Epidemiology of Pediatric HIV Infection. In: Wormser GP, ed.

AIDS and Other Manifestations of HIV Infection. New York: Raven Press, 1992:17-24 Simonds RJ, Rogers MF. Epidemiology of HIV Infection in Children. In: Crocker AC, Cohen HJ,

Kastner TA, eds. HIV infection and developmental disabilities. Baltimore: Paul H. Brookes Publishing Co. 1992:1-13

Kaplan JE, Abrams E, Shaffer N, Cannon RO, Kaul A, Krasinski K, Bamji M, Hartley RM, Roberts

Martha F. Rogers, M.D., FAAP – August 2012

11

B, Kilbourne B, Thomas P, Rogers M, Heneine W. Low risk of mother-to-child transmission of HTLV-II in non-breast-fed infants. J Infect Dis 1992

Jones DS, Byers RH, Bush TJ, Oxtoby MJ, Rogers MF. The epidemiology of transfusion-associated AIDS in children in the United States, 1981-1989. Pediatrics 1992; 89:123-127.

Ellerbrock TV, Lieb S, Harrington PE, Bush TJ, Schoenfisch SA, Oxtoby MJ, Howell JT, Rogers

MF, Witte JJ. Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med 1992; 327:1704-9.

Nesheim S, Lee F, Sawyer M, Jones D, Slade B, Shaffer N, Homes R, Grimes V, Rogers M,

Czerkinsky C, Nahmias A. Diagnosis of human immunodeficiency virus infection by enzyme-linked immunospot (ELISPOT) assays in a prospectively-followed cohort of infants of HIV-seropositive women. Pediatr Infect Dis J 1992; 11:635-9.

Parekh, B, Shaffer N, Schochetman G, Rogers MF, et al. Dynamics of maternal IgG antibody

decay and HIV-specific antibody synthesis in infants born to seropositive mothers. AIDS and Human Retroviruses . Rogers MF, Caldwell B, Simonds RJ, Gwinn M. Epidemiology of pediatric human

immunodeficiency virus infection in the United States. Ann of the New York Academy of Sciences 1993;693:4-8.

Simonds RJ, Rogers MF. USPHS guidelines for prevention of transmission of HIV through

transplantation of human tissues and organs. J Transplant Coordination 1993;3:154-1556. Simonds RJ, Oxtoby MJ, Caldwell MB, Gwinn ML, Rogers MF. Pneumocystis carinii pneumonia

among US children with perinatally acquired HIV infection. JAMA 1993;270:470-3. Fowler MG, Mofenson L, Rogers M. Syposium-in-writing. Clinical Immunology and

Immunopathology 1994;71:1. Thomas PA, Weedon J, Krasinski K, Abrams E, Shaffer N, Matheson P, Bamji M, Kaul A, Hutson

D, Grimm KT, Beatrice ST, Rogers M, and the New York City Perinatal HIV Transmission Collaborative Study Group. Maternal predictors of perinatal human immunodeficiency virus transmission. Pediatr Infect Dis J 1994;13:489-95.

Rogers MF, Caldwell MB, Gwinn ML, Simonds RJ. Epidemiology of pediatric human

immunodeficiency virus infection in the United States. Acta Pediatr 1994;Suppl 400:5-7. Rogers MF, Jaffe HW. Reducing the risk of maternal-infant transmission of HIV: a door is open

Martha F. Rogers, M.D., FAAP – August 2012

12

[editorial]. N Engl J Med 1994;331:1222-3. Rogers MF, Schochetman G. HIV infection in children. In: Schochetman G, George JR, eds.

AIDS Testing. New York: Springer-Verlag 1994:266-83. Simonds RJ, Lindegren ML, Thomas P, Hanson D, Caldwell B, Scott G, Rogers MF. Prophylaxis

against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N Engl J Med 1995;332:786-90.

Rogers MF, Mofenson LM, Moseley RR. Reducing the risk of perinatal HIV transmission

through zidovudine therapy: treatment recommendations and implications for perinatal HIV counseling and testing. JAMWA 1995;50:78-82.

Abrams EJ, Matheson PB, Thomas PA, Thea DM, Krasinski K, Lambert G, Shaffer N, Bamji M,

Hutson D, Grimm K, Kaul A, Bateman D, Rogers M, and the NYC Perinatal HIV Transmission collaborative Study Group. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. Pediatrics 1995;96:451-458.

Matheson PB, Abrams EJ, Thomas P, Hernan MA, Thea DM, Lambert G, Krasinski K, Bamji M,

Rogers MF, Heagarty M, and the NYC Perinatal HIV Transmission Collaborative Study Group. Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type I. J Infect Dis 1995;172:353-8.

Lobato MN, Spira TJ, Rogers MF, Laboratory Task Force. CD4+ T lymphocytopenia in children:

lack of evidence for a new AIDS agent. Pediatr Infect Dis J 1995;14:527-35. Rogers, MF. Epidemiology of HIV/AIDS in women and children in the United States. Acta

Scandinavia Paediatrica 1996. Mansergh G, Haddix AC, Steketee RW, Nieburg PI, Hu DJ, Simonds RJ, Rogers MF. Cost-

effectiveness of short-course zidovudine to prevent perinatal HIV type i infection in a sub-Saharan African developing country setting. JAMA 1996;276:139-145.

Fowler MG, Rogers MF.Overview of perinatal HIV infection. J Nutrician 1996;126:2602S-7S. Smith DK, Rogers MF. Immunopathogenesis and detection of HIV infection in women and

newborns. Clin OBGYN 1996;39:277-91. Gorsky RD, Farnham PG, Straus WL, Caldwell B, Holtgrave DR, Simonds RJ, Rogers MF, Guinan

ME. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention. Public Health Reports 1996;111:335-41.

Martha F. Rogers, M.D., FAAP – August 2012

13

Rogers MF, van Griensven GJ. AIDS 1997 Epidemiology: overview. AIDS 1997;11 Suppl A:S55-

6. Reggy AA, Rogers MF, Simonds RJ. Using 3'-azido-2',3'-dideoxythymidine (AZT) to prevent

perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis. [editorial] J Natl Cancer Inst 1997;89:1566-7.

Rogers MF. Epidemiology of HIV/AIDS in women and children in the USA. Acta Paediatr

Supplement 1997;421:15-6. DeCock K, Shaffer N, Wiktor S, Simonds RJ, Rogers M. Ethics of HIV Trials. Lancet

1997;350:1546-47. Rogers MF, Lindegren ML. Epidemiology of Pediatric HIV Infection. In: Wormser GP, ed. AIDS

and Other Manifestations of HIV Infection. New York: Lippencott-Raven Publishers, 1998:19-25 Simonds RJ, Rogers MF, Dondero TJ. Ethics of placebo-controlled trials of zidovudine to

prevent the perinatal transmission of HIV in the Third World [letter; comment] N Engl J Med 1998;338:836-7.

Bangkok Collaborative Perinatal HIV Transmission Study Group. The Bangkok short-course

zidovudine trial to reduce perinatal HIV transmission: summary of findings and operational issues. Prenat Neonat Med 1999;4(Suppl 1):1-7.

Rogers MF, Shaffer Nathan. Reducing the risk of maternal-infant transmission of HIV by

attacking the virus. N Engl J Med 1999;341:441-443. Lindegren ML, Byers RH, Thomas P, Davis SF, Caldwell B, Rogers MF, Gwinn M, Ward JW,

Fleming PL. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999;282:577-579 DeCock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, Alnwick DJ, Rogers M, Shaffer

N. Prevention of mother-to-child HIV transmission in resource-poor countries. JAMA 2000;283:1175-1182.

Rogers MF, guest ed. HIV/AIDS in Infants, Children, and Adolescents. The Pediatric Clinics of

North America. February 2000. Rogers MF, Stockton PL. Organizational approaches to the HIV/AIDS Crisis, Centers for Disease

Control and Prevention. Annals New York Academy of Sciences

Martha F. Rogers, M.D., FAAP – August 2012

14

Kellerman SE, Sullivan PS, Lee LM, Lindegren ML, Rogers MF. Epidemiology: report from the 7th Conference on Retroviruses and Opportunistic Infections. JAMA [Newsline]. Available at: http://www.ama-assn.org/special/hiv/newsline/conferen/retro00/retro00.htm. Accessed 3/29/00. [R]

Zaff JF, Smith DC, Rogers MF, Leavitt CH, Halle TG, Bornstein MH. In: Bornstein MH, Davidson

L, Keyes CL, Moore KA, & The Center for Child Well-being, eds. Well-being: positive development across the life course. Mahwah, NJ: Erlbaum, (in press).

Leavitt C, Tonniges T, Rogers MF. Good nutrition—Imperative for positive development. In:

Bornstein MH, Davidson L, Keyes CL, Moore KA, & The Center for Child Well-being, eds. Well-being: positive development across the life course. Mahwah, NJ: Erlbaum, (in press).

Swartzendruber A, Rogers MF. Orphanhood and the Effects of HIV/AIDS on Children and

Families. HIV Forefront 2001;3:2-4. King S, Lindegrin ML, Rogers MF. Epidemiology of Pediatric HIV Infection in the United States.

In: Wormser G, ed. AIDS and other manifestations of HIV infection. New York, NY: Academic Press (in press).

Pregnancy and HIV infection: a European consensus on management. Newell ML, Rogers MF,

eds. AIDS 2002;16:Supplement 2. Achievements, Issues, and Challenges: Prevention of Mother-to-Child HIV Transmission in the

United States and in Resource-Limited Settings. Amer J OBGYN 2007;197, issue 3, supplement 1. (Guest Editor)

Patricia L. Riley, Stephen M. Vindigni, John Arudo, Agnes N. Waudo, Andrew Kamenju, Japheth

Ngoya, Elizabeth O. Oywer, Chris P. Rakuom, Marla E. Salmon, Maureen Kelley, Martha Rogers, Michael E. St. Louis, Lawrence H. Marum (2007) Developing a Nursing Database System in Kenya Health Services Research 42 (3p2) , 1389–1405 doi:10.1111/j.1475-6773.2007.00715

Gross J.M.,1 Riley P.L.,2 Kiriinya R.,3 Rakuom C.,4 Willy R.,4 Kamenju A.,3 Oywer E.,5 Wambua D.,5

Waudo, A.,3 Rogers M.F.1 Using Information Systems to Analyze the Impact of the Emergency Hire Plan on the Nursing Shortage and Nurse Distribution in Kenya. Bull World Health Organ 2010;88:824–830 | doi:10.2471/BLT.09.072678

Gross JM, Rogers M, Teplinsky I et al. The impact of outmigration on the nursing workforce in

Kenya. Health Services Research, in press Rogers M, Taylor A, Neisheim S. Prevention Perinatal Transmission of HIV: the National

Perspective. J Public Health Management Practice, 2010, 16(6), 505–508

Martha F. Rogers, M.D., FAAP – August 2012

15

Vindigni S, Riley P, Kimani F, Willy R, Warutere P, Sabatier J, Kiriinya K, Friedman M, Osumba M, Waudo A, Rakuom C, Rogers M. Kenya’s emergency hire nursing program: a pilot evalution of health service delivery in two districts. Human Resources for Health 2014;12:16

Wakaba M, Mbindyo P, Ochieng J, Todd J, Kiriinya R, Waudo A, Rakuom C, Noor A, Rogers M, English M.

The Public Sector Nursing Workforce in Kenya – A County Level Analysis. Human Resources for

Health 2014, 12:6

Appiagyei A, Kiriinya R, Gross J, Wambua D, Oywer E, Kamenju A, Higgins M, Riley P, Rogers M.

Using trends in training capacity and registration to inform the scale-up of the nursing workforce in Kenya. (in clearance)

Book Chapter (as APA citations, in reverse chronological order)

Book Reviews (as APA citations, in reverse chronological order)

Research Abstracts and Proceedings (as APA citations, in reverse chronological order)

Instructional Booklet (as APA citations, in reverse chronological order)

Educational Software (as APA citations, in reverse chronological order)

Video (as APA citations, in reverse chronological order)

Martha F. Rogers, M.D., FAAP – August 2012

16

SCHOLARSHIP: PRESENTATIONS

International Presentations (as APA citations, in reverse chronological order)

National Presentations (as APA citations, in reverse chronological order)

Local, State, and Regional Presentations (as APA citations, in reverse chronological order)

TEACHING ACTIVITIES

Courses Taught Dates NXXX Name of Course Role in course Fall NRSG 710 Principles in Health

Outcomes Research

Coordinator

Spring NRSG 733 Health Risk, Interventions, and Outcomes

Coordinator

Fall EPI 591 Epidemiology of HIV and STD Transmission

Guest lecturer

Fall

NRSG 701 Policy

Guest lecturer

Doctor of Philosophy in Nursing Advisement 2008-2012 2009 – present 2007 – 2010 2013 - Present

Dissertation Committee Member for Rebecca Wheeler Dissertation Committee Member for Hanna Demeke Dissertation Committee Member for Mabel Magowe Chair, Dissertation Committee for Jennifer Vanderlaan

Martha F. Rogers, M.D., FAAP – August 2012

17

Master of Science in Nursing Thesis Advisement Year

Name of Student, “Title of Thesis”, Role (i.e., Thesis Chair)

2003 Chassea Golden, MPH/MSN, “Barriors to PMTCT in Kenya”, (thesis advisor)

Master of Public Health Thesis Advisement 19XX-Present Name of Student, “Title of Thesis”, Role (i.e., Thesis Chair)

2002 Kate Meiners, MPH, “AIDS Orphans in Cameroon”, (thesis advisor)

2003 Alison Swint, MPH, “PMTCT in Kenya”, (thesis advisor)

2004 Rebecca Carter, MPH, “ Evaluation of a Family Health Campaign”

2005 Erin Jones, MPH, “AIDS Orphans”

2006 Cristin Haggard, MPH candidate, “Monitoring and Evaluation of OVC Projects”

2008 Jessica Gross, MPH candidate, “ Outmigration of Kenyan Nurses”

2010 Ashley Appiagyei, MPH candidate, “Nurse Training in Kenya”

2011 Megan Thompson, MPH candidate, “Disparities in Nurse Distribution in Kenya”

PROFESSIONAL AND UNIVERSITY SERVICE ACTIVITIES

Membership in Professional Organizations

Date Name of organization

1981-present American Academy of Pediatrics

1990-2000 Sigma Xi

1983-present EIS Alumni

1981-present Commissioned Officers Association

Editorships and Editorial Boards 19xx-Present Editor, Journal (italicized) 1995-2003

Editorial Board, AIDS

Manuscript Reviewer 19xx-Present Reviewer, Journal (italicized)

Martha F. Rogers, M.D., FAAP – August 2012

18

1985-Present Reviewer, New England Journal of Medicine

1995-Present Reviewer, AIDS

1985-Present Reviewer, JAMA

1990-Present Reviewer, American Journal of Pediatrics

1991-Present Reviewer, Lancet

1992-1999+ Reviewer, American J OBGYN

National and International Consultation

Year Activity

1982 Investigated unusual hepatitis-like illness in missionary population in Bangladesh.

1986 Responsible for initiating study of perinatal transmission of HIV in population of African women in Kinshasa, Zaire

Lectured in several foreign countries

1992- 1995 Appointed to Steering Committee for Epidemiological Research for the Global Program on

AIDS, World Health Organization

1994 Member UNAIDS Coordinating Committee for the Reduction of Perinatal Transmission of HIV

Travel to Thailand, Ivory Coast, and several other countries for consultation on clinical trials of AZT for the prevention of perinatal transmission of HIV

Responsible for coordinating and directing UNAIDS HIV collaborating center at CDC.

Directed project sponsored by the World Bank to assess needs of children orphaned by the HIV/AIDS epidemic.

1982 New Brunswick Task Force on Reye Syndrome and the Environment, New Brunswick, Canada, March

1982 NIH Consensus Conference on Reye Syndrome, Washington, D.C., May 1982.

1985 CDC Consultant Committee for School Attendance of HIV-Infected Children, June 1985. Responsible for publication of guidelines (MMWR 1985; 34:517)

1987 Chair, CDC Consultant Committee for Developing the Case Classification System for HIV in Children, September 1986. Document published (MMWR 1987; 36:225)

1987 Planning Committee for the Surgeon General's Conference on Pediatric AIDS, Philadelphia

1988 Member of the Secretary of HHS Task Force on Pediatric AIDS. March - August 1988.

Martha F. Rogers, M.D., FAAP – August 2012

19

1988 Consultant to National Association of State Boards of Education, June 1988. Document published and widely disseminated to education departments.

1989 Member of the Technical Panel on Prevention and Control of Infectious Diseases in Child Care Settings, American Academy of Pediatrics and American Public Health Association, June 1989-present.

1989 Member of the planning committee for the Fifth National Pediatric AIDS Conference

1989 Planning Committee for Surgeon General's Workshop on Pediatric AIDS

1989 Consultant for World Health Organization committee on early diagnosis of HIV infection in infants, October 1989.

1989 Member of the scientific advisory committee for conference "AIDS--The Implications for Mothers and Children", Paris, France

1989- 1990 CDC representative to the PHS Panel on Women, Adolescents, and Children with HIV Disease

and AIDS, Chaired by Drs. Antonia Novello and James Allen

1990 Member of the scientific review committee for the Sixth International Conference on AIDS

1990 Chair, Consultants Committee for the Development of Guidelines for the Prevention and Management of HIV Infection in Women and Their Children

1991 Member of planning committee for the Sixth Annual National Pediatric AIDS Conference

1990 Member of the scientific advisory committee for the International Symposium on AIDS and Reproduction, Genoa, Italy

1990 Chair, Technical Working Group for Strategic Planning for Prevention of HIV Infection in Women and Children. Coordinated working group composed of representatives from several national centers at CDC. Developed document that serves as guidepost for prevention activities.

1990 CDC Chair, PHS Conference on Early Diagnosis of HIV Infection in Infants. Washington, D.C.

1991 Member of the scientific review committee for the Seventh International Conference on AIDS.

1991 Chair, Consultants Committee for the Development of Guidelines for the Prevention of HIV Transmission from Transplantation of Tissues/Organs.

1991 CDC Representative to the PHS Workgroup on Organ and Tissue Transplantation. Report submitted to Dr. Mason 1991.

1991 Member, Epidemiology and Technology Transfer Subcommittee of the Acquired Immunodeficiency Syndrome Research Review Committee, National Institute of Allergy and Infectious Diseases, appointed July 1991.

Member, American Academy of Pediatrics Provisional Committee on AIDS

1992 Chair, Idiopathic CD4+ T-lymphocytopenia Syndrome Task Force, Appointed July 1992.

Martha F. Rogers, M.D., FAAP – August 2012

20

1993 Member, WHO Steering Committee on Epidemiological Research and Forecasting for the Global Program on AIDS

1994 Member, UNAIDS Committee for the Prevention of Mother-to-child Transmission of HIV Member, Scientific Advisory Board for the Antiretroviral Use in Pregnancy Registry

1994 Member, USPHS Task Force on the Prevention of Perinatal Transmission of HIV

1996 Member, Review committee for the Fogarty International Foundation, 1996

1998 Member, Program Advisory Committee for the Pediatric AIDS Foundation, 1998-present

1999 Member, Editorial Board of HIV Forefront

1999 Member, Department of HHS Workgroup on Use of Antiretroviral Agents for Prevention of Perinatal HIV Infection

2008 -2009 Member, PEPFAR Prevention of Mother-to-Child Transmission Panel

Visiting Professorships N/A

National and International Scientific Review

Year Name of Panel

1983-2000 Assumed the lead role in developing the following policy documents including organizing expert consultations, consensus building, writing, clearance, and dissemination.

1985 MMWR 1985;34:517. Education and Foster Care of Children Infected with Human T-lymphotropic Virus Type III/Lymphadenopathy-associated Virus.

1985 MMWR 1985;34:721. Recommendations for Prevention of Perinatal Transmission of Human T-lymphotropic Virus Type III/Lymphadenopathy-associated Virus and AIDS

1987 MMWR 1987;36:225. Classification System for HIV Infection in Children Under 13 Years of Age.

1994 MMWR 1994;43:RR-8. Guidelines for Preventing Transmission of HIV Through Transplantation of Human Tissues and Organs.

1995 MMWR 1995;44:RR-7. U.S. Public Health Service Recommendations for HIV Counseling and Voluntary Testing for Pregnant Women.

2001 MMWR 2001;50:RR-19. Revised Recommendations for HIV Screening of Pregnant Women.

Martha F. Rogers, M.D., FAAP – August 2012

21

Emory University Service Year Role, Name of Committee or Group

2002-2004 Member, International Affairs Committee

Nell Hodgson Woodruff School of Nursing Service N/A

Other Community Service Year Role, Name of Committee or Group

Volunteer technical assistance to Reach-Out, a non-profit organization in Kenya